This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stankova, J. Articles by Rozen, R. Search for Related Content PubMed PubMed Citation Articles by Stankova, J. Articles by Rozen, R.

Antisense Inhibition of Methylenetetrahydrofolate Reductase Reduces Cancer Cell Survival In vitro and Tumor Growth In vivo

Departments of Human Genetics, Pediatrics and Biology, McGill University-Montreal Children's Hospital, Montreal, Quebec, Canada

Requests for reprints: Rima Rozen, Montreal Children's Hospital Research Institute, 4060 Saint Catherine Street West, Room 242, Montreal, Quebec, Canada H3Z 2Z3. Phone: 514-412-4358; Fax: 514-412-4331; E-mail: rima.rozen{at}mcgill.ca.

Purpose: Many cancer lines are methionine dependent and decrease proliferation when methionine supply is limited. Methylenetetrahydrofolate reductase (MTHFR) generates the folate derivative for homocysteine remethylation to methionine. We investigated the effect of antisense-mediated inhibition of MTHFR on survival of human cancer cells.

Experimental Design: We examined the in vitro and in vivo anticancer effects of a combination of MTHFR antisense and standard cytotoxic drugs.

Results: Specific antisense against MTHFR (EX5) showed significant inhibitory effects on growth of human colon, lung, breast, prostate, and neuroblastoma tumor cells in vitro compared with that of the control oligonucleotide. Cytotoxic drugs (5-fluorouracil, cisplatin, or paclitaxel) potentiated the effect of EX5. In vivo, antisense alone or in combination with cytotoxic drugs inhibited the growth of human colon and lung carcinoma xenografts. In comparison with control oligonucleotide, treatment with EX5 inhibited growth of colon tumors and lung tumors by 60% and 45%, respectively. EX5 with 5-fluorouracil decreased growth of colon tumors by an additional 30% compared with EX5 alone, and EX5 with cisplatin decreased growth of lung tumors by an additional 40% compared with cisplatin alone. Growth inhibition by EX5 was associated with decreased amounts of MTHFR protein and with increased amounts of an apoptosis marker.

Conclusions: Our results confirm that MTHFR inhibition decreases tumor growth and suggest that inhibition of MTHFR by antisense or small molecules may be a novel anticancer approach.

Key Words: methionine dependence • folate • phosphorothioate oligonucleotides

This article has been cited by other articles:

				W. Zhang, O. A. Press, C. A. Haiman, D. Y. Yang, M. A. Gordon, W. Fazzone, A. El-khoueiry, S. Iqbal, A. E. Sherrod, G. Lurje, et al. Association of Methylenetetrahydrofolate Reductase Gene Polymorphisms and Sex-Specific Survival in Patients With Metastatic Colon Cancer J. Clin. Oncol., August 20, 2007; 25(24): 3726 - 3731. [Abstract] [Full Text] [PDF]